Regulators Conclude Merck's Gardasil Is Safe

Law360, New York (July 23, 2008, 12:00 AM EDT) -- U.S. regulators concluded Tuesday that Merck & Co. Inc.’s Gardasil remains safe and effective protection against a virus that causes cervical cancer despite reports of adverse effects, including death and paralysis.

After reviewing more than 9,700 reports of adverse effects, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention said Gardasil, which was approved two years ago, remains safe for use in girls and women between 9 and 26 years of age.

Ninety-four percent of the reports were nonserious events —...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.